financetom
Business
financetom
/
Business
/
Musk says his companies are looking to invest in Argentina
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Musk says his companies are looking to invest in Argentina
Oct 3, 2024 12:57 AM

(Reuters) - Elon Musk, the CEO of Tesla and SpaceX, said in an X post on Tuesday that his companies are looking for ways to invest in Argentina and support the South American nation.

Argentina is the world's fourth-largest producer of lithium, which is needed for many of the batteries used in electric vehicles.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq
BRIEF-Linqto Says Preparing A Registration Statement To File For A Potential IPO Listing On Nasdaq
Oct 2, 2024
Sept 30 (Reuters) - Linqto: * LINQTO: PREPARING A REGISTRATION STATEMENT TO FILE FOR A POTENTIAL IPO LISTING ON NASDAQ Source text for Eikon: ...
Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports
Asset manager TPG close to buying Germany's Techem for $7.8 bln, Financial Times reports
Oct 2, 2024
Sept 30 (Reuters) - U.S.-based asset manager TPG is close to finalizing a 7 billion euro ($7.80 billion) deal to acquire German metering firm Techem, the Financial Times reported on Monday, citing people familiar with the matter. TPG may reach an agreement to acquire Techem from Switzerland's Partners Group as soon as Monday, FT added. ($1 = 0.8977 euros) ...
US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
US Judge Dismisses $6.4 Billion Suit Against Bristol Myers Over Delay in Drug Approvals
Oct 2, 2024
02:26 PM EDT, 09/30/2024 (MT Newswires) -- Bristol-Myers Squibb Company ( BMY ) won a dismissal of a $6.4 billion lawsuit alleging it delayed a Federal Drug Administration approval process for a Celgene drug in order to avoid paying Celgene shareholders for meeting certain milestones. As part of its deal to acquire Celgene, Bristol-Myers Squibb ( BMY ) issued Celgene...
Annovis Bio Files Patents for Combination Therapies Using Buntanetap
Annovis Bio Files Patents for Combination Therapies Using Buntanetap
Oct 2, 2024
02:21 PM EDT, 09/30/2024 (MT Newswires) -- Annovis Bio ( ANVS ) said Monday it filed three new patents for combination therapies involving its lead compound buntanetap with Trulicity or Viagra, or both. The therapies aim to treat neurodegenerative diseases, including Alzheimer's and Parkinson's, the company said, adding that early data shows potential cognitive improvement in preclinical studies using these...
Copyright 2023-2026 - www.financetom.com All Rights Reserved